| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 203071 | CC-90009 | 1860875-51-9 | 98% | ![]() |
| CC-90009 是一种 cereblon (CRBN) E3 连接酶调节剂。CC-90009 与 CRBN 特异性 | ||||
| 23178 | AC-90179 HCl | 359878-19-6 | 98% Min. | ![]() |
| AC-90179 is a high selective 5-hydroxytryptamine2A receptor inverse agonist. It is an | ||||
| 2051510 | LML-134 | 1542135-76-1 | 98% | ![]() |
| LML134 是一种具有口服活性,高选择性 H3R (组胺 3 受体) 反向激动剂 | ||||
| 2051515 | Asapiprant | 932372-01-5 | 98% Min. | ![]() |
| Asapiprant 是一个强效且有选择性的 DP1 受体拮抗剂,其 Ki 值为 0.44 | ||||
| 615201 | CLEFMA | 1246964-32-8 | 98% Min. | ![]() |
| CLEFMA has anti-proliferative activity in H441 cells. CLEFMA may induce autophagic ce | ||||
| 20732 | Lanraplenib | 1800046-95-0 | 98% | ![]() |
| GS-9876(lanraplenib)是一种高度选择性的口服SYK抑制剂,主要用于狼 | ||||
| 52004 | Belnacasan | 273404-37-8 | 98% | ![]() |
| Belnacasan (VX-765) 是 VRT-043198 的口服生物活性前药,VRT-043198 是有效 | ||||
| 2071401 | Pimodivir ( VX-787 ) | 1629869-44-8 | 98% Min. | ![]() |
| Pimodivir (VX-787) 是一种可口服的甲型流感病毒聚合酶抑制剂,通过 | ||||
| 21224 | BI-187004 | 1303515-32-3 | ≧98.0% | ![]() |
| BI-187004, also known as VTP-34072, is an 11β-hydroxysteroid dehydrogenase 1 inhibit | ||||
| 21257 | Difelikefalin | 1024828-77-0 | ≧98.0% | ![]() |
| Difelikefalin HCl is in stock.Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is | ||||
| 20367 | Piflufolastat | 1423758-00-2 | ≧96% | ![]() |
| Piflufolastat, also known as DCFPYL is a PSMA-targeted PET imaging agent for prostate | ||||
| 20278 | PD-159206 | 171744-42-6 | ≧94.0% | ![]() |
| PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HI | ||||
